You have successfully logged out.

Hello !
Logout

Reducing Underdosing

Underdosage 
a cause of medication errors

On average, a patient receives ten medications per day and will be subject to at least one medication error per day.1,2

Underdosage happens when patients do not receive the full dose of their prescribed drug. lt is an often overlooked and underappreciated cause of medication errors.

Medical Professional

This information is meant for medical professionals only. Please confirm that you are a medical professionals before accessing the information.

Confirm Yes, I am a health care professional. Cancel No, I am not a health care professional.
nurse checks intrafix safeset flush
  • In 50ml infusions 

    0%

    of the active agent in the residual volume remains in the IV line.3

  • Up to

    0%

    Of the drug is underdosed during antibiotic therapy.4

  • In small-volume infusions up to

    0%

    of the prescribed dose may not be administered.5

ecoflac-icon-green-16-9
virus-icon-green-16-9
ambulance-icon-16-9
money-icon-green-16-9
Health care team in light blue scrubs sitting around a table in a bright hospital setting, discussing patient care with a laptop and coffee cups on the table

Educate staff

Raise awareness about the problem of underdosage.
In one study, oncology was the only area where flushing was standard practice, in other areas it was optional.16

nurse checks intrafix safeset flush

Select special IV administration sets 

 Use microbore administration sets to minimize dead volume.17 
Administer drugs through sets whose inherent design ensures that residual volume is reduced to an absolute minimum.

Cyto-Set: IV set for preparation and administration of multiple cytotoxic drugs in a closed system

Cyto-Set® Infusomat® Space

Single-use, sterile infusion system for the preparation and administration of different cytotoxic drugs via one single closed line-system by gravity or pressure with bottles and bags according to the SPC (Summary of product characteristics) of the drugs/solutions. Cyto-Set® is used for the application of cytotoxic agents in a closed system. The Cyto-Set® system reduces the probability of contamination of person and environment when preparing and applying cytotoxic drugs ensured by its technical components forming a closed system and the resulting workflow. Cyto-Set® Infusomat® SpaceIV administration set for the application of cytostatics. For infusion by compatible pumps.Connection set for the administration of cytostatic drugs by compatible pumps. Cyto-Set® Infusomat® Space is primed with a flushing solution (NaCl 0,9% or Glucose 5%). Cyto-Set® Mix or Cyto-Set® Line must be connected to the valve port of Cyto-Set® Infusomat® Space to administer the cytostatic drugs. One drug administration is always followed by a flushing step.Cyto-Set® can be used for all patients to whom cytotoxic drugs are prescribed in hospitals. Depending on the particular therapeutical concept and sensibility of the tumor to one or more cytotoxic agents the administration of these drugs represents an important role besides surgery and radiation therapy.

Cyto-Set® Infusion 

Single-use, sterile infusion system for the preparation and administration of different cytotoxic drugs via one single closed line-system by gravity or pressure with bottles and bags according to the SPC (Summary of product characteristics) of the drugs / solutions. Cyto-Set® is used for the application of cytotoxic agents in a closed system. The Cyto-Set® system reduces the probability of contamination of person and environment when preparing and applying cytotoxic drugs ensured by its technical components forming a closed system and the resulting workflow.Cyto-Set® InfusionIV administration set. Only for gravity infusion.Connection set for the administration of cytostatic drugs by gravity. Cyto-Set® Infusion is primed with a flushing solution (NaCl 0,9% or Glucose 5%). Cyto-Set® Mix or Cyto-Set® Line must be connected to the valve port of Cyto-Set® Infusion to administer the cytostatic drugs. One drug administration is always followed by a flushing step.Cyto-Set® can be used for all patients to whom cytotoxic drugs are prescribed in hospitals. Depending on the particular therapeutical concept and sensibility of the tumor to one or more cytotoxic agents the administration of these drugs represents an important role besides surgery and radiation therapy.

References

1. Toh MR et al, Prev Med Reports 2014;1:43-47

2. Hughes RG et al, Evidence-based Handbook for Nurses 2008; US Dept of Health and Human Services

3. Plagge H et al, EJHPSCience 2010;16:31-37

4. Dixon R, Hampshire Hospital Foundation Trust, Available via: Are you under infusing IV antibiotic infusions?

5. Cousins D et al, Clinical Pharmacist 2018;10(12):356-357

6. Cooper DM et al, Bri J Nurs 2018;27:2-6

7. Gregerson BG et al, Proc Bayl Univ Med Cent 2018;31(2):168-170

8. Chan YK et al, CMBES Proc., vol 36, no1, May 2013;26.

9. Institute for Safe Medication Practices (ISMP), ISMP Newsletter Volume 25, Issue 24; December 3, 2020, Available via: Hidden Medication Loss When Using a Primary Administration Set for Small-Volume Intermittent Infusions

10. Maclachlan L, Hull University Teaching Hospitals NHS Trust, Available via: Ensuring full prescribed dose delivery of IV antibiotics in OPAT11. 

11. Fish and Ohlinger, Crit Care Clin 2006;22(2):291-311

12. Centers for Disease Control and Prevention (CDC), Department of Health and Human Services, December 2019; Available via: Antibiotic Resistance Threats in the United States13. Fish and Ohlinger, 2006

13. O’Neill J, Review on Antimicrobial Resistance; December 2014; Available via: Antimicrobial Resistance: Tackling a Crisis for the Health and Wealth of Nations14. CDC 2015, https://www.cdc.gov/drugresistance/biggest-threats.html

14. Bowman S et al, Anaesthesia 2013;68:557-561

15. Gurney H et al, Bri J Cancer 2002;86:1297-1302

16. Cooper DM et al, BJON 2018;27(14):S4-S12

17. Institute for Safe Medication Practices (ISMP), ISMP Medication Safety Alert! Volume 25, Issue 24; April 8, 2021, Available via: Additional Strategies to Improve Complete Delivery of Small-Volume Intermittent Infusions

18. Peyko V J Pharm Pract 2023;36(2):194-197